Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > 5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-ylmethyl)piperazin-1-yl]carbonyl}-N-(5-fluoro-2-methylpyrimidin-4-yl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine
5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-ylmethyl)piperazin-1-yl]carbonyl}-N-(5-fluoro-2-methylpyrimidin-4-yl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine structure, CAS 1046787-18-1

5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-ylmethyl)piperazin-1-yl]carbonyl}-N-(5-fluoro-2-methylpyrimidin-4-yl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine

CAS Number1046787-18-1

SynonymsMFCD28900747

Molecular FormulaC25H37FN8O2

Molecular Weight500.612

Purity

Density1.3±0.1 g/cm3

Boiling Point622.8±55.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1170339 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1046787-18-1 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1046787-18-1
Catalog No.2A-1170339
Chinese NamePKC-IN-1
SynonymsMFCD28900747
Molecular FormulaC25H37FN8O2
Molecular Weight500.612
Density1.3±0.1 g/cm3
Boiling Point622.8±55.0 °C at 760 mmHg
Storage Condition2-8℃
ApplicationPKC-IN-1 is a potent, ATP-competitive, reversible PKC inhibitor with Ki values of 5.3 and 10.4 nM for human PKCβ and PKCα, respectively, and IC50 values for human PKCα, PKCβI, PKCβII, PKCθ, PKCγ, PKC
PubChem ID57249754
SMILESCc1ncc(F)c(Nc2n[nH]c3c2CN(C(=O)N2CC(C)N(CC4CCOCC4)CC2C)C3(C)C)n1
InChIInChI=1S/C25H37FN8O2/c1-15-12-33(16(2)11-32(15)13-18-6-8-36-9-7-18)24(35)34-14-19-21(25(34,4)5)30-31-22(19)29-23-20(26)10-27-17(3)28-23/h10,15-16,18H,6-9,11-14H2,1-5H3,(H2,27,28,29,30,31)/t15-,16+/m1/s1
InChI KeyDKXZBPBWIGORKP-CVEARBPZSA-N
Transport InfoProduct name: PKC-IN-1
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA